BusinessCesca Therapeutics to Announce Second Quarter Fiscal 2016 Results and Provide a Status Update to Investors on February 16, 2016By Nasdaq OMXFeb 11, 2016, 11:00 AM UTC
BusinessImmucor and Sirona Genomics Announce CE Mark for MIA FORA™ NGS HLA Typing SolutionBy Nasdaq OMXFeb 3, 2016, 4:41 PM UTC
BusinessOryzon Genomics to Present at the 18th Annual BIO CEO & Investor Conference 2016By Nasdaq OMXFeb 2, 2016, 1:00 PM UTC
BusinessData Highlighted From 3 Studies Demonstrate Complementarity of BioNano Genomics’ Next-Generation Mapping to SequencingBy Nasdaq OMXJan 11, 2016, 12:00 PM UTC
